<p>CAR T therapy has delivered remarkable results for people with certain blood cancers&mdash;sometimes sending aggressive disease into deep remission after a single infusion. But today, only about 20% of eligible patients can actually get it. In this episode, sponsored by our partners at Allogene Therapeutics, Katie sits down with Dr. Zachary Roberts to unpack why access remains so limited and how new allogeneic (or &ldquo;off-the-shelf&rdquo;) CAR T therapies could be a turning point. They discuss how using healthy donor T-cells, rather than a patient&rsquo;s own, may help bypass manufacturing hurdles and bring advanced treatment to more oncologists, more hospitals, and more communities. To learn more, visit&nbsp;<a href="https://alpha3trial.com/?utm_source=podcast&utm_medium=banner&utm_campaign=KCM_podcast&utm_id=alpha3">Alpha3trial.com</a>. #AllogenePartner</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

A CAR T Revolution: Allogene is Bringing Lifesaving Cancer Treatment to More Patients

Next Question with Katie Couric

AI Chapters

AI Insights

Reviews